| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Technical Officer | SVP, Chief Technical Officer
1 company
Labarre Michael J. is a SVP, Chief Technical Officer at HALOZYME THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $12.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $36.00 | $720,000.00 | -6.2% | +6.5% | +53.6% | |
| Dec 13, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $40.01 | $800,262.27 | -4.2% | -0.4% | +13.6% | |
| Nov 15, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $39.43 | $788,670.00 | -4.2% | -11.9% | +37.2% | |
| Oct 17, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $36.52 | $365,200.00 | -6.2% | -3.2% | +42.3% | |
| Sep 19, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $39.10 | $390,980.00 | -6.2% | -2.4% | +56.7% | |
| Aug 22, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $42.41 | $424,070.00 | -3.2% | -6.3% | +45.6% | |
| Jul 18, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $40.43 | $404,300.00 | -6.6% | -11.2% | +31.3% | |
| Jun 21, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $36.00 | $360,000.00 | -6.6% | +10.1% | +40.8% | |
| Apr 18, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $36.00 | $360,000.00 | -6.6% | +12.8% | +6.5% | |
| Feb 27, 2023 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 10,000 | $49.55 | $495,482.98 | -3.4% | -32.3% | -17.9% |